Swiss National Bank’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-59,000	Closed	-$934K	–	2424
2024 Q4	$934K	Buy	59,000 +2,700	+5%	+$140K	﹤0.01%	2228
2024 Q3	$3.27M	Sell	56,300 -500	-0.9%	-$24.7K	﹤0.01%	1573
2024 Q2	$2.6M	Buy	56,800 +6,900	+14%	+$371K	﹤0.01%	1678
2024 Q1	$3.3M	Buy	49,900 +9,000	+22%	+$534K	﹤0.01%	1561
2023 Q4	$1.63M	Sell	40,900 -4,700	-10%	-$147K	﹤0.01%	1968
2023 Q3	$1.45M	Buy	45,600 +2,100	+5%	+$78.4K	﹤0.01%	2030
2023 Q2	$1.75M	Buy	43,500 +7,800	+22%	+$342K	﹤0.01%	1973
2023 Q1	$1.52M	Sell	35,700 -1,600	-4%	-$80.8K	﹤0.01%	2009
2022 Q4	$1.79M	Buy	37,300 +3,100	+9%	+$145K	﹤0.01%	1957
2022 Q3	$1.29M	Buy	34,200 +1,100	+3%	+$38.1K	﹤0.01%	2181
2022 Q2	$915K	Buy	33,100 +2,700	+9%	+$118K	﹤0.01%	2416
2022 Q1	$1.65M	Buy	30,400 +2,300	+8%	+$118K	﹤0.01%	2138
2021 Q4	$1.64M	Hold	28,100	–	–	﹤0.01%	2185
2021 Q3	$1.11M	Hold	28,100	–	–	﹤0.01%	2383
2021 Q2	$1.19M	Buy	28,100 +7,500	+36%	+$406K	﹤0.01%	2402
2021 Q1	$1.27M	Hold	20,600	–	–	﹤0.01%	2259
2020 Q4	$1.45M	Buy	+20,600	New	+$1.3M	﹤0.01%	2095